The term "ectocytosis" is applied to the shedding of right-sideout membrane vesicles from surface of virtually all eukaryotic cells (2, 25) . Various patterns of this process occur in lymphocytes, (1) , monocytes (6) , neutrophils (25) , platelets (9) , endothelial cells (15) , fibroblasts (14) and epithelial cells (3, 18, (22) (23) (24) . Various stimuli contribute to or enhance the shedding of vesicles from cells. In neutrophils, shedding of the cell surface membranes seems to be triggered as a cellprotection mechanism (25) . In fibroblasts, its induction seems to be stress related (14) . After fertilization or parthenogenetic activation about 15-25% of surface labeled material is released from surface of the ovum suggesting that activation of these cells is associated with the shedding or modification of cell surface components (13) . The outer segment of the photoreceptor cells, rods and cones is made of a stack of closed discs that are derived from and are contained within the plasma membrane. Shedding of these discs from the rod outer segment occurs daily in most vertebrate species on a rhythmic basis and in response to exposure to light (19) . Thus, vesicular shedding seems to be a significant part of the life-cycle of cells of various lineages. A major question however, is whether vesicles play a role in modulating the biologic behavior of the cell with which they interact. Consistent with the idea that vesicles are biologically active, it was shown that vesicles shed from peripheral blood leukocytes stimulated erythroid cells to proliferate. This activity was sensitive to mild proteolysis or heat denaturation. In addition, the activity seemed to be associated with the vesicle surface rather than intravesicular molecules (7) . Vesicles released from endothelial cells by coincubation with tumor cell spheroids exhibited procoagulant activity (15) . These findings suggest that vesicles shed from cells may be biologically active.
When activated with plant lectin "conconavalin (Con)-A" or IL-2, lymphocytes become activated. They express IL-2 receptor, produce IL-2 and proliferate (5). However, this activation is short-lived (5) and lymphocytes grown in vitro eventually undergo cell death (4, 21) . Since vesicular structures are shed from lymphocytes when they are maintained in vitro, in this report we examined the potential roles that these structures play in IL-2 receptor expression, proliferation as well as apoptosis of leukocytes.
MATERIALS AND METHODS

Reagents
Mouse monoclonal antibodies to IL-2 receptor ("CD25" Becton Dickinson), bromodeoxyuridine (incorporates in cells in S-phase, Becton Dickinson), Ki67 (present in cells in the cell cycle and absent in the Go cells; Dako Corp, Carpinteria, CA), MPM-2 (present in the mitotic cells; Dr PN Rao, Univ of Texas, MD Anderson Hospital and Tumor Institute, Houston, Texas), BM1 (raised against Ley antigen) and a rabbit polyclonal antiserum to Con-A (Sigma Chem Co, St Louis, MO) were used. Con-A was purchased from Sigma. Avidin and biotinylated peroxidase and biotinylated horse anti-mouse antibody and goat anti-rabbit were obtained from Vector Laboratories (Burlingame, CA). Recombinant human interleukin-2 (rIL-2, 22 X 105 Units/mg protein) was received from Hoffmann-La Roche (Nutley, NJ).
Isolation and treatment of human peripheral blood leukocytes (PBL)
Peripheral blood mononuclear cells depleted from polymorphonuclear leukocytes were prepared by centrifugation of buffy coats over Ficoll-Hypaque. Hut78 (T) cell line was obtained from ATCC (Rockville, MD). Nutrient medium for all cultures consisted of D-MEM/F-12 containing 10% heat inactivated and Mycoplasma-and virus-tested fetal bovine serum, antibiotic-antimycotic mixture, human insulin (200 U/L, ER Squibb & Sons, Princeton, NJ), transferrin (25 mg/L, Gibco-BRL, Grand Island, NY), and glucose (400 mg/L, Sigma, St Louis, MO). Cell viability was determined by trypan blue exclusion. Ultrastructural examination of leukocytes isolated from peripheral blood, as well as Hut78 failed to reveal contamination by bacteria, viruses or Mycoplasma. Contamination of leukocyte cultures by bacterial and Mycoplasma was also repeatedly ruled out by PCR as described (28) . PBL were grown in the absence of stimulating signal in the nutrient medium or medium complemented with Con-A (5 /Cg/ ml), rIL-2 (100 U/ml), and vesicles (100 pg protein/2 X 106 PBL) derived from Con-A or IL-2 activated PBL. Cells were examined on day 0-4 of culturing. For determination of proliferative activity, PBL were incubated with BrdU (10-5 M) for 30 min before termination of the experiment. Isolation of vesicles Vesicles were collected from 3-day culture media of human PBL (1 x 106 cells/ml) maintained in presence of Con-A (5 pg/ml) or IL-2 (100 U/ml) and culture medium of Hut-78 cells as descirbed (26) .
Immunostaining, Light, and ultrastructural studies Immunostaining, light and ultrastructural studies were performed as previously described (27) .
RESULTS
Membrane-bound vesicles are present in the culture medium of PBL activated with Con-A or IL-2
We isolated membrane-bound vesicles from culture media of peripheral blood leukocytes that were activated in presence of Con-A (5 /Cg/ml) and rIL-2 (100 U/ml) as previously described (26) . We will refer to the vesicles derived respectively from Con-A and IL-2 activated PBL as Con-A and IL-2 vesicles.
Effect of vesicles on expression of CD25 in PBL PBL that were grown in the absence of either Con-A or IL-2 remained as single cells and did not aggregate (Fig. 1A) . Con-A agglutinates a variety of somatic and germ cell lines presumably by virtue of its multiple valence for cell surface receptors (20) . PBL stimulated with Con-A aggregated within hours after addition of Con-A and after 48 hr large colonies of PBL were evident. Similarly, PBL to which Con-A vesicles were added aggregated in a fashion similar to that induced by Con-A (Fig. 1B) . IL-2 resulted in cell aggregation, however, the aggregates were smaller in number or size as compared to those induced by Con-A or Con-A vesicles. However, vesicles derived from IL-2 activated PBL failed to induce aggregation of PBL.
After appropriate stimulation with activating signals such as Con-A or IL-2, resting peripheral blood lymphocytes become activated, express IL-2 receptor and produce IL-2 (5). In order to examine the expression of CD25, PBL were incubated with Con-A (5 pg/ml), IL-2 (100 U/ml), and with Con-A
FIG. 2. Effect of vesicles derived from peripheral blood leukocytes (PBL) on the expression of CD25 in PBL.
A: PBL freshly isolated from peripheral blood were incubated for three days in nutrient medium without (Non-activated PBL) and with Con-A (5 pg/ml) (+Con-A), Con-A (5 ig/ml)+rabbit antiserum of Con-A (1/300 dilution) (+Con-A, +Con-A antibody), vesicles (100 ig protein/2 X 106 PBL) derived from Con-A avtivated PBL (+PBL yes), Con-A vesicles (100 pg protein/2 X 106 PBL) and rabbit antiserum to Con-A (+PBL yes, +Con-A antibody) and Hut-78 vesicles (100 /tg protein/2 X 106 PBL) (+Hut-78 yes). Cells were immunostained for CD25 and the percentages of immunoreactive cells were determined by cell counting under a light microscope. B: PBL freshly isolated from peripheral blood were incubated for three days in nutrient medium without (Non-activated PBL) and with Con-A (5 pg/ml) (+Con-A), Con-A vesicles (100 ICg protein/2 X 106 PBL) derived from Con-A activated PBL (+PBL yes, Con-A derived), IL-2 (100 U/ml) (+IL-2) and with IL-2 vesicles (100 pg protein/2 X 106 PBL) (+PBL yes, IL-2 derived). Cells were immunostained for CD25 and the percentages of immunoreactive cells were determined by cell counting. The data shown are the means and standard deviations obtained from triplicate samples.
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and IL-2 vesicles (100 pg protein/2 X 106 PBL). On the days 3 and 4 after incubation, PBL were removed and air dried over slides. The cells were then immunostained for CD25 and then the percentages of immunostained cells were determined. Consistent with their inactivated state, majority of PBL that were maintained in vitro in the absence of stimulating signal, failed to express CD25 ( Fig. 2A) . In contrast, a large number of cells in the PBL preparations that were maintained in presence of Con-A or IL-2 expressed CD25 ( Fig. 2A) . Con-A vesicles also induced expression of CD25 on PBL.
Immunostaining showed however, that at a given time, this expression was more enhanced in the PBL activated with Con-A vesicles than with Con-A (Figs. 2A, B, 3A, B) . We entertained the possibility whether Con-A potentially present on Con-A vesicles induces activation and expression of CD25 by PBL. Immunostaining of these vesicular preparations demonstrated a strong immunoreactivity for Con-A on Con-A activated PBL and vesicles derived from these cells whereas vesicles derived from IL-2 activated PBL and Hut-78 T cells grown in the absence of Con-A were not immunoreactive for Con-A (data not shown).
Western blot analysis of Con-A vesicles also showed presence of Con-A in Con-A vesicles (Fig. 4) . Furthermore, in order to demonstrate that activation of PBL by Con-A vesicles is due to Con-A, a number of controls were performed. Induction of PBL freshly isolated from peripheral blood with vesicles derived from PBL activated with IL-2 or with Hut-78 failed to induce expression of CD25 on these cells ( Fig. 2A,  B) . In addition, presence of a rabbit antiserum to Con-A in the culture medium of PBL inhibited the ability of both Con-A and Con-A vesicles to induce expression of CD25 on PBL (Fig. 2B) . A: PBL freshly isolated from peripheral blood were incubated in nutrient medium with Con-A (5 pg/ml) for 3 days. Cells were immunostained for CD25. Numerous cells express CD25, however, some cells are not immunoreactive or are only slightly immunoreactive (arrowheads). X 300 B: PBL freshly isolated from peripheral blood were incubated in nutrient medium complemented with Con-A vesicles (100 /eg protein/2 X 106 PBL) for 3 days. Cells were immunostained for CD25. A large number of cells are immunoreactive for CD25. The staining is intense in some PBL (large arrowheads). The vesicles also express CD25, some of which are bound to PBL membrane (small arrowheads).
X 300
Effect of vesicles on proliferation of PBL Unless activated, mature T lymphocytes are in a resting state in vitro and in vivo. Their growth is arrested in the Go phase of the cell cycle and they do not proliferate despite presence of adequate nutrient in culture medium (12) . Consistent with their inactivated resting state, PBL that were maintained in nutrient medium did not express a significant number of Ki67+, or MPM-2+ positive cells (data not shown) and did not incorporate BrdU (Fig. 5) . However, after appropriate mitogenic signal such as Con-A or IL-2, lymphocytes exhibited a proliferative response. The number of PBL that were immunoreactive for Ki67 or MPM-2 and the cells that incorporated BrdU increased significantly after stimulation with either Con-A or IL-2 (Fig. 5) . As evidenced by Ki67, and MPM-2 expression as well as by incorporation of BrdU, Con-A vesicles induced proliferation of PBL that exceeded from that seen by Con-A (Fig. 5) . In contrast, IL-2 vesicles did not show an ability to induce proliferation of PBL (Fig. 5) .
Effect of vesicles on apoptosis of PBL
Lymphocytes have a finite lifespan both in vitro and in vivo (21) . Resting PBL or PBL that are activated to proliferate with an activation signal ultimately die by apoptosis (programmed cell death) (10). On day 3-4 of culturing, PBL that were grown in the nutrient medium alone, were examined at the light and ultrastructural levels. These cells were found to have the morphologic appearance of unstimulated cells. They were small in size, had small amounts of cytoplasm, and rarely showed presence of mitotic figures. However, some apoptotic cells were present in these preparations (Fig. 6A) . At the ultrastructural level, apoptotic cells were identified by their characterisitic morphology including margination and
FIG. 6. Effect of vesicles derived from peripheral blood leukocytes (PBS) in induction of apoptosis in PBL.
A: PBL (1 x 106 cell/ml) were incubated in nutrient medium for 4 days. After this period, cells were examined at the ultrastructural level. PBL show a resting state as manifested by their small size, small amount of cytoplasm and condensed heterochromatin. Mitotic figures are rare, however, some apoptotic cells are observed (arrowheads). X 2200 B: PBL (1 x 106 cell/ml) were incubated in nutrient medium complemented with Con-A (5 ,ig/ml) for 4 days. As compared to cells portrayed in Fig 6A, B , the cells are larger, and have significantly higher amounts of cytoplasm. The heterochromatin is not as dense and nucleoli are more prominent. Mitotic figures (arrowhead) are frequently found in these cultures, x 2200 C: PBL (1 x 106 cell/ml) were incubated in nutrient medium complemented with Con-A vesicles (100,ig protein/2 x 106 PBL) for 4 days. The morphologic features of these cells is similar to that seen in Fig 6B. Large arrowhead points to a mitotic PBL and small arrowhead points to an apoptotic PBL. X 2200 D: PBL (1 x 106 cell/ml) were incubated in nutrient medium complemented with IL-2 vesicles (100 ig protein/2 x 106) for 4 days. Majority of cells have undergone apoptosis or are undergoing apoptosis (large arrowheads). Cells that have remained have the morphologic appearance of non-activated cells (small arrowheads). x2200
Effect of vesicles derived from peripheral blood leukocytes (PBL) on proliferation of PBL. PBL freshly isolated from peripheral blood were incubated for three days in nutrient medium without (Non-activated PBL) and with Con-A (5 ig/ml) (+Con-A), Con-A vesicles (100 ig protein/2 x 106 PBL) derived from Con-A activated PBL (+PBL yes, Con-A derived), IL-2 (100 U/ml) and with IL-2 vesicles (100 ig protein/2 x 106 PBL) (+PBL yes, IL-2 derived). Thirty min prior to removal cells were incubated with bromodeoxyridine (BrdU, 10-5 M). Cells were immunostained for BrdU and the percentages of immunoreactive cells were determined by cell counting. The data shown are the means and standard deviations obtained from triplicate samples. SHED  FROM  CON-A  AND IL-2  ACTIVATED  PBL ON PROLIFERATION  OF PBL condensation of their heterochromatin, and blebbing of the plasma membrane. Segmentation of cells and their nuclei resulted in the formation of the so-called apoptotic bodies. In sharp contrast, cells activated with Con-A had morphologic features of stimulated cells. They were large with abundant amount of cytoplasm. Numerous mitotic figures and few apoptotic cells were present (Fig. 6B) . The morphologic features of PBL incubated with Con-A vesicles was similar to that observed after activation of PBL with Con-A (Fig. 6C) . When PBL were incubated with IL-2 vesicles for 3-4 days, a large number of cells exhibited apoptosis and numerous apoptotic bodies were present (Fig. 6D) . The cells that were remaining had morphologic appearance of unstimulated cells and mitotic figures were not present. These ultrasturctural findings correlated well with the cell viability determined by the ability of cells to exclude trypan blue. Induction of apoptosis by IL-2 vesicles was time-dependent. Fig 7 is representative of one of four experiments with similar results. Approximately 20% of cells underwent cell death within 24 hr after incubation of PBL with IL-2 vesicles. In sharp contrast, majority of cells incubated for the same duration with nutrient medium alone, or with medium complemented with Con-A, IL-2 or Con-A vesicles were viable. Although a gradual loss of viability was seen in all cultures, the number of dead cells in those cultures that were incubated with IL-2 vesicles remained consistently higher (Fig. 7) . A smaller but detectable effect on enhancement of apoptosis was also consistently observed in those cultures that were incubated with Con-A vesicles (Fig. 7) . Recently, Ley which reacts with the monoclonal antibody BM 1 was shown to be present in a variety of cells that undergo apoptosis both in vitro and in vivo (8) . As compared with non-activated PBL or those incubated with Con-A, IL-2 or Con-A vesicles, more cells immunoreactive for Ley were present in the IL-2 vesicle treated PBL (Fig. 8A, B) .
COMPARISON OF THE EFFECT OF VESICLES
DISCUSSION
We showed that vesicles shed from mononuclear cells can regulate several aspects of PBL function such as expression of IL-2 receptor, apoptosis and cell proliferation. It was previously shown that vesicles shed from peripheral blood leukocytes stimulate erythroid cells to proliferate. In addition, the activity seemed to be associated with the vesicle surface rather than intravesicular molecules (7) . As shown here, the proliferative response that was inducible by vesicles was not related to a protein expressed on vesicles, rather to the Con-A that was associated with these structures. Therefore, the ability of vesicles derived from phytohemagglutinin (PHA) activated mononuclear cells to induce proliferation of erythroid cells may also be attributable to PHA. A number of other evidence suggests, however, that the biological activity of vesicles may be independent of a protein exogenously expressed on their surface. For example, vesicles released from endothelial cells by co-incubation with tumor cell spheroids exhibited procoagulant activity (15) .
Vesicles derived from IL-2 activated PBL induced apoptosis in PBL freshly isolated from peripheral blood. Effect of Con-A vesicles on apoptosis was less significant. Apoptosis was demonstrated by the loss of cell viability, development of characteristic morphology of apoptotic cells and expression of BM1. FIG. 7 . Effect of vesicles derived from peripheral blood leukocytes (PBL) on viability of PBL. PBL freshly isolated from peripheral blood were incubated for three days in nutrient medium without (control) and with Con-A (5 pg/ml) (Con-A), Con-A vesicles (100 ig protein/2 X 106 PBL) derived from Con-A activated PBL (Con-A vesicle), IL-2 (100 U/ml) (IL-2) and with IL-2 vesicles (100 ig protein/2 X 106 PBL) derived from IL-2 activated PBL (IL-2 vesicle). The viability of cells was determined immediately after isolation from peripheral blood (Day 0) and on days 1, 2 and 3 of culture. At each time point, the viability was determined by the ability of the cells to exclude trypan blue. The data shown are the means and standard deviations obtained from triplicate samples.
EFFECT OF LEUKOCYTE VESICLES ON CELL VIABLITY OF PBL
Since Con-A induces expression of IL-2 receptor and production of IL-2 (5), PBL activated with Con-A may eventually shed vesicles derived from IL-2 activated PBL and that the small but detectable effect of Con-A vesicles on apoptosis may be related to presence of the IL-2 vesicles in these cultures. The ability to induce apoptosis by these vesicles may be partially masked by mitogenic activity of the Con-A vesicles. The signal(s) that induce apoptosis in mononuclear cells maintained in vitro is not known. However, apoptosis of lymphocytes and monocytes can be induced in various experimental conditions. For example, OKT3 induces apoptosis of activated T cells (11) . Monoclonal antibodies to TCR/CD3 complex induce proliferation of cloned TCR z.3+ T cells. However, in presence of IL-2, the same antibodies induce apoptosis in the same T cells (17) . It was shown that IL-4 enhances programmed cell death in stimulated human monocytes (16) and IL-2 induces apoptosis in mouse thymocytes (17) . As shown here, vesicles derived from IL-2 activated PBL also exhibit the ability to induce apoptosis in these cells.
In conclusion, we demonstrated that leukocyte vesicles shed as pelletable extracellular structures exert distinct effects on expression of IL-2 receptor, proliferation and apoptosis of PBL. Vesicles derived from Con-A activated PBL induce proliferation and expression of IL-2 receptor in PBL whereas vesicles derived 
